Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-10T10:53:29.499Z Has data issue: false hasContentIssue false

Dementia patients have greater anti-cholinergic drug burden on discharge from hospital: A multicentre cross-sectional study

Published online by Cambridge University Press:  13 August 2021

J. Randall*
Affiliation:
School Of Medicine, Cardiff University, Cardiff, United Kingdom
A. Hook
Affiliation:
School Of Medicine, Cardiff University, Cardiff, United Kingdom
C-M. Grubb
Affiliation:
School Of Medicine, Cardiff University, Cardiff, United Kingdom
N. Ellis
Affiliation:
School Of Medicine, Cardiff University, Cardiff, United Kingdom
J. Wellington
Affiliation:
School Of Medicine, Cardiff University, Cardiff, United Kingdom
A. Hemmad
Affiliation:
Medical School, Newcastle University, Newcastle, United Kingdom
A. Zerdelis
Affiliation:
James Cook University Hospital, Middlesbrough, United Kingdom
B. Geers
Affiliation:
School Of Medicine, University of Manchester, Manchester, United Kingdom
B. Sykes
Affiliation:
Medical School, University of Exeter, Exeter, United Kingdom
C. Auty
Affiliation:
School Of Medicine, University of Manchester, Manchester, United Kingdom
C. Vinchenzo
Affiliation:
Lancaster Medical School, Faculty Of Health And Medicine, Lancaster University, Lancaster, United Kingdom
C. Thorburn
Affiliation:
Medical School, University of Bristol, Bristol, United Kingdom
D. Asogbon
Affiliation:
Birmingham Medical School, College Of Medical And Dental Sciences, University of Birmingham, Birmingham, United Kingdom
E. Granger
Affiliation:
Acute Medicine, University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal, United Kingdom
H. Boagey
Affiliation:
Medical Sciences Division, University of Oxford, Oxford, United Kingdom
J. Raphael
Affiliation:
Norwich Medical School, University of East Anglia, Norwich, United Kingdom
K. Patel
Affiliation:
Medical School, Newcastle University, Newcastle, United Kingdom
K. Bhargava
Affiliation:
Medical School, Newcastle University, Newcastle, United Kingdom
M.-K. Dolley
Affiliation:
Medical School, Bart’s and The London School of Medicine and Dentistry, London, United Kingdom
M. Maden
Affiliation:
School Of Medicine, University of Manchester, Manchester, United Kingdom
M. Shah
Affiliation:
School Of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
Q. Lee
Affiliation:
School Of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
R. Vaidya
Affiliation:
Medical School, Newcastle University, Newcastle, United Kingdom
S. Sehdev
Affiliation:
Medical School, University College London, London, United Kingdom
S. Barai
Affiliation:
Cardiff University Brain Research Imaging Centre (cubric), Cardiff University, Cardiff, United Kingdom
S. Roche
Affiliation:
Medical School, University of Bristol, Bristol, United Kingdom
U. Khalid
Affiliation:
Institute Of Psychiatry, King’s College London, London, United Kingdom
J. Harrison
Affiliation:
Cardiff University Brain Research Imaging Centre (cubric), Cardiff University, Cardiff, United Kingdom
D. Codling
Affiliation:
Institute Of Psychiatry, King’s College London, London, United Kingdom
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Anticholinergic medications block cholinergic transmission. The central effects of anticholinergic drugs can be particularly marked in patients with dementia. Furthermore, anticholinergics antagonise the effects of cholinesterase inhibitors, the main dementia treatment.

Objectives

This study aimed to assess anticholinergic drug prescribing among dementia patients before and after admission to UK acute hospitals.

Methods

352 patients with dementia were included from 17 hospitals in the UK. All were admitted to surgical, medical or Care of the Elderly wards in 2019. Information about patients’ prescriptions were recorded on a standardised form. An evidence-based online calculator was used to calculate the anticholinergic drug burden of each patient. The correlation between two subgroups upon admission and discharge was tested with Spearman’s Rank Correlation.

Results

Table 1 shows patient demographics. On admission, 37.8% of patients had an anticholinergic burden score ≥1 and 5.68% ≥3. At discharge, 43.2% of patients had an anticholinergic burden score ≥1 and 9.1% ≥3. The increase was statistically significant (rho 0.688; p=2.2x10-16). The most common group of anticholinergic medications prescribed at discharge were psychotropics (see Figure 1). Among patients prescribed cholinesterase inhibitors, 44.9% were also taking anticholinergic medications.

Conclusions

This multicentre cross-sectional study found that people with dementia are frequently prescribed anticholinergic drugs, even if also taking cholinesterase inhibitors, and are significantly more likely to be discharged with a higher anticholinergic drug burden than on admission to hospital.

Conflict of interest

This project was planned and executed by the authors on behalf of SPARC (Student Psychiatry Audit and Research Collaborative). We thank the National Student Association of Medical Research for allowing us use of the Enketo platform. Judith Harrison was su

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.